Editorial: Women in head and neck cancer, volume II: 2022

Editorial: Women in head and neck cancer, volume II: 2022

Bibliographic Details
Main Authors:	Panagiota Economopoulou, Ioannis Kotsantis, Amanda Psyrri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Oncology
Subjects:	head and neck cancer HPV oropharyngeal cancer oral cancer sex disparities erlotinib
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1278798/full

Similar Items

Special Issue about Head and Neck Cancers: HPV Positive Cancers
by: Panagiota Economopoulou, et al.
Published: (2020-05-01)

De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Panagiota Economopoulou, et al.
Published: (2021-09-01)

Editorial: Women in head and neck cancer 2021
by: Panagiota Economopoulou, et al.
Published: (2022-12-01)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
by: Panagiota Economopoulou, et al.
Published: (2020-11-01)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
by: Alexander Rühle, et al.
Published: (2021-05-01)

The Role of B Cells in Head and Neck Cancer
by: Niki Gavrielatou, et al.
Published: (2021-10-01)

The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Imogen Sharkey Ochoa, et al.
Published: (2022-09-01)

Impact of Human Papillomavirus-Negative Dominance in Oropharyngeal Cancer on Overall Survival: A Population-Based Analysis in Germany from 2018 to 2020
by: Mussab Kouka, et al.
Published: (2023-11-01)

A pilot study to improve pain phenotyping in head and neck cancer patients
by: Yi Ye, et al.
Published: (2023-05-01)

HPV in head and neck cancer
by: Bhawna Sirohi
Published: (2011-01-01)

Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
by: Jade Z. Zhou, et al.
Published: (2021-12-01)

HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
by: Jason K. Wasserman, et al.
Published: (2017-01-01)

miRNAs as Biomarkers for Diagnosing and Predicting Survival of Head and Neck Squamous Cell Carcinoma Patients
by: Igor Piotrowski, et al.
Published: (2021-08-01)

Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Panagiota Economopoulou, et al.
Published: (2021-01-01)

The Role of Dental Practitioners in the Management of Oncology Patients: The Head and Neck Radiation Oncology Patient and the Medical Oncology Patient
by: Adepitan A. Owosho, et al.
Published: (2023-05-01)

Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer
by: Matthew Shew, et al.
Published: (2019-08-01)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
by: Marieke Bamps, et al.
Published: (2021-07-01)

Understanding Cachexia in Head and Neck Cancer
by: Sivaramakrishnan Muthanandam, et al.
Published: (2021-01-01)

Nutritional Support in Head and Neck Radiotherapy Patients Considering HPV Status
by: Adam Brewczyński, et al.
Published: (2020-12-01)

Frequency of Human Papillomavirus Genotypes in Head and Neck Epithelial Cancers in the Ear, Throat, and Nose Department of Shafa Hospital, Kerman, Iran in 2017
by: Soolmaz Ghorbani, et al.
Published: (2021-07-01)

Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong
by: Zigui Chen, et al.
Published: (2024-01-01)

Current status and future perspectives of oral HPV testing in the diagnosis and monitoring of oropharyngeal cancer. A review
by: Zuzana Horákova, et al.
Published: (2023-12-01)

A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide
by: Amanda F. Carlander, et al.
Published: (2021-07-01)

Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors
by: Ourania N. Kostopoulou, et al.
Published: (2022-06-01)

The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes
by: Jane Harrowfield, et al.
Published: (2021-02-01)

Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire
by: Scott Anderson, et al.
Published: (2017-10-01)

Human Papillomavirus-Associated Head and Neck Cancers. Where are We Now? A Systematic Review
by: Pinkiewicz M, et al.
Published: (2022-11-01)

Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas
by: Snežana Hinić, et al.
Published: (2022-09-01)

Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea
by: Hyun Woong Jun, et al.
Published: (2022-01-01)

Community socioeconomic status and rural/racial disparities in HPV−/+ head and neck cancer
by: Jason Semprini, et al.
Published: (2023-06-01)

Multi-Domain Screening: Identification of Patient’s Risk Profile Prior to Head-and-Neck Cancer Treatment
by: Monse W. M. Wieland, et al.
Published: (2023-11-01)

Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma
by: Emily Z. Yan, et al.
Published: (2023-04-01)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
by: Jérôme R. Lechien, et al.
Published: (2020-04-01)

Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study
by: Marta Tagliabue, et al.
Published: (2020-11-01)

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer
by: Qiang Xu, et al.
Published: (2022-12-01)

Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center
by: Julius M. Vahl, et al.
Published: (2021-02-01)

Human papillomavirus genome variants and head and neck cancers: a perspective
by: Jean-Damien Combes, et al.
Published: (2018-04-01)

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
by: Eric Y. Du, et al.
Published: (2022-11-01)

Increased Abundances of CD16<sup>+</sup> Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4<sup>+</sup> T Cell Disturbances in Oropharyngeal Cancer
by: Christian Idel, et al.
Published: (2022-06-01)

PD1<sup>+</sup>CD8<sup>+</sup> Cells Are an Independent Prognostic Marker in Patients with Head and Neck Cancer
by: Barbora Pokrývková, et al.
Published: (2022-11-01)